LANXESS Aktiengesellschaft (ETR:LXS)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.61B -18.3% |
| Revenue (ttm) | 5.67B -10.9% |
| Net Income | -577.00M |
| EPS | -6.68 |
| Shares Out | 86.35M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.10 (0.54%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | 163,644 |
| Average Volume | 967,043 |
| Open | 18.62 |
| Previous Close | 18.60 |
| Day's Range | 17.93 - 18.82 |
| 52-Week Range | 11.03 - 29.50 |
| Beta | 1.20 |
| RSI | 54.79 |
| Earnings Date | May 7, 2026 |
About ETR:LXS
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the ag... [Read more]
Financial Performance
In 2025, ETR:LXS's revenue was 5.67 billion, a decrease of -10.89% compared to the previous year's 6.37 billion. Losses were -577.00 million, 226.0% more than in 2024.
Financial StatementsNews
Lanxess shares plunge after Advent calls off Envalior stake deal
Lanxess shares were set for their worst day ever after the German specialty chemicals maker said the sale of its stake in plastics joint venture Envalior had been called off, one of the first deals ...
Bernard Horn's Top 5 Trades of the 3rd Quarter
Bernard Horn (Trades, Portfolio), manager of the Polaris Global Value Fund, disclosed this week that his firm's top five trades included new positions in Alrosa PJSC ( MIC:ALRS , Financial) and Discov...
2021 expected to be strong as industries begin to strengthen, Lanxess CEO says
Matthias Zachert, CEO of Lanxess, discusses the German chemical company's full-year earnings.
Kalama Chemical 'a perfect fit,' Lanxess CEO says on acquisition
Lanxess CEO Matthias Zachert discusses the rationale for the company's acquisition of Emerald Kalama Chemical for $1.1 billion.